Overview
Lycopharm is a Polish company offering natural lycopene-based supplements, including lycopene juices and the LycopenPRO and LycopenVIT products. The company works with scientific and medical institutions to develop products containing the natural antioxidant lycopene.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-01-14. Active
49 1090 1056 0000 0001 5586 0994- 50 1090 1056 0000 0001 5664 9683
Bank spółdzielczy62 8232 0005 0000 1485 2000 0020
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $288.8K$288,800 |
Buildings and premises | $407.6K$407,552 |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Lycopharm holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2024.
| Mark | Protected until | |
|---|---|---|
| LYCOPHARM | Jan 5, 2034 | |
| LYCOPENVIT | Jan 5, 2034 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the only member of the management board is authorised to represent the company acting independently. In the case of a management board consisting of two (2) to five (5) persons, the company may be represented by any two members of the management board acting jointly, a member of the management board acting jointly with a commercial proxy, or two commercial proxies acting jointly (joint commercial power of attorney).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mariusz Wojciech Książek (54) | 1,000 | $2,701,242.57 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zentis Polskasp. z o.o. | $139,792,140.72 | zentis.pl | ||
| WarwinS.A. | $45,684,822.23 | warwin.pl | ||
| Vin-KonS.A. | $13,393,173.21 | vinkon.com.pl | ||
| Premium Rosasp. z o.o. | $10,653,161.35 | premiumrosa.eu | ||
| Sadvitsp. z o.o. | $8,668,465.63 | sadvit.pl | ||
| Chias Brothers Europesp. z o.o. | $4,935,357.96 | chias.eu | ||
| Katrex Tradesp. z o.o. | $2,813,521.55 | katrextrade.com | ||
| Zakład Przetwórstwa Owocowo-Warzywnego Vitapol Drzymałasp. j. | $784,400.96 | vitapol.net | ||
| Starparksp. z o.o. | $158,671.90 | starpark.com.pl | ||
| Sokołyksp. z o.o. | $2,471.30 | sokolyk.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-04-29 | Address change (Ul. Emilii Plater 14/13/17, 00-669, Warszawa → Ul. Prosta 32, 00-838, Warszawa) | |
| 2023-04-29 | Name change (Lycopene Health → Lycopharm) | |
| 2022-04-14 | Share capital change (9,000,000.00 PLN → 10,000,000.00 PLN) | |
| 2022-03-01 | Share capital change (8,000,000.00 PLN → 9,000,000.00 PLN) | |
| 2021-11-27 | Share capital change (5,000,000.00 PLN → 8,000,000.00 PLN) |
FAQ
Last updated: 2026-10-07